23 May, EOD - Indian

SENSEX 81721.08 (0.95)

Nifty 50 24853.15 (0.99)

Nifty Bank 55398.25 (0.83)

Nifty IT 37403.55 (0.95)

Nifty Midcap 100 56687.75 (0.64)

Nifty Next 50 67095.9 (0.57)

Nifty Pharma 21434.25 (-0.41)

Nifty Smallcap 100 17643.35 (0.80)

23 May, EOD - Global

NIKKEI 225 37160.47 (0.47)

HANG SENG 23601.26 (0.24)

S&P 5826.75 (-0.72)

LOGIN HERE

companylogoSandu Pharmaceuticals Ltd

You are Here : Home > Markets > CompanyInformation > Company Background
BSE Code : 524703 | NSE Symbol : | ISIN : INE751D01014 | Industry : Pharmaceuticals - Indian - Formulations |


Chairman's Speech

Dear Shareholders, Customers, and Employees,

I am delighted to present to you the Annual Report of Sandu Pharmaceuticals limited for the fiscal year [2024]. This report encapsulates the significant achievements, milestones and the overall progress we have made over the past year. It also provides a comprehensive outlook on our strategic direction and the future we envision.

Reflecting on Our Journey:

The year 2023-24 has been one of unprecedented challenges and remarkable resilience. Following the world pandemic that had pushed us to the limit, we saw the public making a diligent effort to improve their general well-being and health. .Our Company's core values are health and happiness, and Ayurveda has gained popularity as a reliable and mainstream wellness option.Thanks to our unwavering commitment to upholding the fundamental principles of Ayurveda while staying on course to satisfy consumer demands, we have emerged stronger and more determined than before.

Financial Highlights:

I am proud to report that despite the challenging economic landscape, we have achieved a commendable financial performance. Our revenue grew by [2.96%], reaching a total of [revenue amount], while our net profit decreased by [3.90%]. This growth is a testament to the robustness of our business model, the strength of our brand, and the loyalty of our customers. We have maintained a strong financial position and are able to fund in important areas like infrastructure, community activities, and research and development despite the challenges of inflation with our captive resources. We continue to be a debt free Company, distribute dividends optimally, whileretaining surpluses for research and development and infrastructure investments in the future.

Innovative Product Development:

Innovation remains the cornerstone of our success. Our dedicated research and development team has worked tirelessly to blend traditional Ayurvedic wisdom with modern scientific research, resulting in products that are both effective and safe. The positive reception of these new offerings has been immensely gratifying and encourages us to continue on this path of innovation.

Commitment to Sustainability:

Our commitment to sustainability is deeply embedded in our corporate ethos. We have made significant strides in reducing our environmental footprint through eco-friendly packaging solutions, sustainable sourcing practices, and energy-efficient operations. Our efforts have not only benefited the environment but have also resonated with our customers who value sustainability. Additionally, our social responsibility initiatives have continued to support health and education in the communities we serve, reinforcing our commitment to holistic well-being.

Looking Ahead:

We have faith in our ability to achieve steady growth and in our strategic orientation as we move to the future. Our key priorities for the coming year include:

1. Market Expansion: We aim to broaden our market presence both domestically and internationally. By leveraging digital platforms and forging strategic partnerships, we will make Ayurveda accessible to a wider audience.

2. Research and Innovation: We will continue to invest in research and development to enhance our product portfolio. Our focus will be on creating innovative, high-quality Ayurvedic solutions that meet the evolving needs of our customers.

3. Customer Focus: Our customers are at the heart of everything we do. We will enhance our customer experience by improving service delivery, expanding distribution channels, and actively engaging with our customers to better understand their needs.

4. Sustainable Practices: Our dedication to sustainability will remain a key priority. We will further our efforts to minimize environmental impact, support organic and sustainable farming, and contribute to the well-being of our communities.

Conclusion:

In conclusion, I would like to extend my heartfelt gratitude to our shareholders for their unwavering support and trust. I also wish to thank our customers for their loyalty and belief in our products. To our employees, your dedication and hard work are the driving forces behind our success. Together, we have achieved remarkable milestones, and I am confident that we will continue to thrive and make a positive impact on the world.

Thank you for your continued support, and let us look forward to another year of growth, innovation, and success.

Warm regards,

Sd/-

CA Shri Balram Viswanathan

DIN:10245195

Chairman

Sandu Pharmaceuticals Limited

   

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +